Eden Research (LON:EDEN) Hits New 12-Month Low – Should You Sell?

Eden Research plc (LON:EDEN)’s share price reached a new 52-week low on Tuesday . The stock traded as low as GBX 1.90 and last traded at GBX 2.12, with a volume of 13468 shares traded. The stock had previously closed at GBX 2.10.

Eden Research Trading Up 1.0%

The firm’s 50-day simple moving average is GBX 2.38 and its 200-day simple moving average is GBX 2.92. The company has a quick ratio of 2.42, a current ratio of 1.95 and a debt-to-equity ratio of 5.41. The firm has a market capitalization of £17.03 million, a PE ratio of -4.78 and a beta of 1.61.

Eden Research (LON:EDEN) last announced its quarterly earnings data on Wednesday, August 26th. The company reported GBX (0.36) earnings per share (EPS) for the quarter. Eden Research had a negative net margin of 50.43% and a negative return on equity of 16.16%. Equities analysts expect that Eden Research plc will post -66.0000038 earnings per share for the current year.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.